Onderneming Freeline Therapeutics Holdings plc
Aandelen
FRLN
US35655L2060
Biotechnologie & Medisch Onderzoek
Vakgebied
Aantal werknemers: 152
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Markus Hörer
FOU | Founder | - | 01-01-15 |
Michael Parini
CEO | Chief Executive Officer | 49 | 15-03-21 |
Paul Schneider
DFI | Director of Finance/CFO | 54 | 16-05-22 |
Chief Tech/Sci/R&D Officer | 57 | 01-03-22 | |
Pamela Foulds
CTO | Chief Tech/Sci/R&D Officer | 55 | 01-11-21 |
James Bircher
COO | Chief Operating Officer | 56 | 01-07-21 |
Naomi Aoki
IRC | Investor Relations Contact | - | - |
Chip McCorkle
LAW | General Counsel | - | - |
Nicole Jones
HRO | Human Resources Officer | 54 | 11-07-22 |
Amy J. Spandau
PRN | Corporate Officer/Principal | - | 01-02-22 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chris Hollowood
CHM | Chairman | 50 | 01-12-15 |
Michael Parini
CEO | Chief Executive Officer | 49 | 15-03-21 |
Paul Schneider
DFI | Director of Finance/CFO | 54 | 16-05-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 65 369 417 | 64 715 513 ( 99,00 %) | 0 | 99,00 % |
Bedrijfsgegevens
Freeline Therapeutics Holdings Plc
Sycamore House Gunnels Wood Road
SG1 2BP, Stevenage
+44 14 3890 6870
http://www.freeline.lifeSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
-1,43% | 103 mld. | |
+8,96% | 101 mld. | |
+4,40% | 23,07 mld. | |
-12,15% | 22,23 mld. | |
-4,36% | 18,05 mld. | |
-39,98% | 17,18 mld. | |
-10,04% | 16,94 mld. | |
+6,79% | 14,07 mld. | |
+38,61% | 12,35 mld. |